Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Beam Therapeutics Inc. BEAM |
BLACKROCK INC BLK |
7,499,930 7.500% |
-248,347 (-3.21%) |
Filing History |
| 2025-04-02 11:02 am Purchase |
2025-03-31 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 10,042,092 10.100% |
4,602,759 (+84.62%) |
Filing History |
| 2025-02-14 4:55 pm Sale |
2024-12-31 | 13G | Beam Therapeutics Inc. BEAM |
ARCH Venture Fund IX, L.P. | 4,600,747 5.600% |
-902,907 (-16.41%) |
Filing History |
| 2025-02-12 09:16 am Sale |
2024-12-31 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 5,439,333 6.600% |
-961,813 (-15.03%) |
Filing History |
| 2025-02-05 7:30 pm Purchase |
2024-12-31 | 13G | Beam Therapeutics Inc. BEAM |
FARALLON CAPITAL PARTNERS LP | 8,239,123 9.900% |
31,000 (+0.38%) |
Filing History |
| 2025-01-10 9:46 pm Sale |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
ARK Investment Management LLC | 6,531,099 7.920% |
-2,862,790 (-30.48%) |
Filing History |
| 2024-11-12 09:50 am Sale |
2024-11-08 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 6,401,146 7.766% |
-2,552,654 (-28.51%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
BLACKROCK INC BLK |
7,748,277 9.400% |
0 (Unchanged) |
Filing History |
| 2024-11-07 09:56 am Purchase |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
FARALLON CAPITAL PARTNERS LP | 8,208,123 9.900% |
4,102,370 (+99.92%) |
Filing History |
| 2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
BLACKROCK INC BLK |
7,748,277 9.400% |
1,086,234 (+16.30%) |
Filing History |
| 2024-10-17 11:50 am Sale |
2024-09-30 | 13G | Beam Therapeutics Inc. BEAM |
STATE STREET CORP STT |
3,929,557 4.800% |
-686,801 (-14.88%) |
Filing History |
| 2024-02-14 3:18 pm Sale |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
ARCH Venture Fund IX, L.P. | 5,503,654 6.800% |
-367,496 (-6.26%) |
Filing History |
| 2024-02-13 5:00 pm Purchase |
2023-12-29 | 13G | Beam Therapeutics Inc. BEAM |
The Vanguard Group | 7,164,843 8.790% |
891,213 (+14.21%) |
Filing History |
| 2024-02-12 3:38 pm Sale |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
FARALLON CAPITAL PARTNERS LP | 4,105,753 5.000% |
-7,716 (-0.19%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 8,953,800 10.985% |
1,184,784 (+15.25%) |
Filing History |
| 2024-02-06 07:27 am Sale |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 3,076,117 3.800% |
-568,456 (-15.60%) |
Filing History |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
ARK Investment Management LLC | 9,393,889 11.530% |
1,180,758 (+14.38%) |
Filing History |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
BLACKROCK INC BLK |
6,662,043 8.200% |
1,423,763 (+27.18%) |
Filing History |
| 2024-01-24 08:42 am Purchase |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
STATE STREET CORP STT |
4,616,358 5.660% |
4,616,358 (New Position) |
Filing History |
| 2023-09-22 3:20 pm Purchase |
2023-09-13 | 13G | Beam Therapeutics Inc. BEAM |
FARALLON CAPITAL PARTNERS LP | 4,113,469 5.200% |
713,548 (+20.99%) |
Filing History |